Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/1996
09/11/1996EP0592564B1 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology
09/11/1996EP0578661B1 Method for the production of collagen; collagen produced through the method and use of collagen
09/11/1996EP0540574B1 Anticoagulant peptides
09/11/1996EP0534944B1 Antibodies specific for elam-1 and the use thereof
09/11/1996EP0532650B1 Method of inducing plant defense mechanisms
09/11/1996EP0531537B1 Hirudin analogue or salt thereof, production thereof, and anticoagulant containing the same as active ingredient
09/11/1996EP0528903B1 Methods of preventing viral replication
09/11/1996EP0484401B1 Production of vascular endothelial cell growth factor
09/11/1996EP0453453B1 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
09/11/1996EP0450099B1 Carrier for binding antiphospholipid antibody, immunoassay using the same, and kit therefor
09/11/1996EP0396741B1 DNA ENCODING [Lys46, Asp97, Asp113] AND [Lys46, Asp113, Asp137] THAUMATIN I POLYPEPTIDES
09/11/1996EP0381719B1 Cellulose binding fusion proteins
09/11/1996EP0372031B1 Biosynthetic osteogenic proteins and osteogenic devices containing them
09/11/1996EP0366710B1 Growth hormone receptor
09/11/1996EP0339086B1 Electrochemiluminescent rhenium moieties and methods
09/11/1996CN1130923A Salmonella vaccines
09/11/1996CN1130911A Multiple branch peptide constructions for use against HIV
09/11/1996CN1130910A Hapten-marked peptides
09/11/1996CN1130866A Anti-angiogenic compositions and method of use
09/11/1996CN1032762C Method of producing peptides
09/10/1996US5554798 Fertile glyphosate-resistant transgenic corn plants
09/10/1996US5554729 Mammalian adrenocorticotropic hormone receptors and uses
09/10/1996US5554728 Lipid conjugates of therapeutic peptides and protease inhibitors
09/10/1996US5554727 Anti-obesity proteins
09/10/1996US5554724 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof
09/10/1996US5554643 Pro-drugs for CCK antagonists
09/10/1996US5554592 Insecticidal toxins from the parastic wasp, bracon hebetor
09/10/1996US5554590 Contacting asthma reversal factor to respiratory epithelium of subject
09/10/1996US5554538 DNA sequences derived from papillomavirus HPV-33 genome
09/10/1996US5554534 Bacillus thuringiensis toxins active against scarab pests
09/10/1996US5554528 Compositions and methods for inhibition of HIV production
09/10/1996US5554526 Human parainfluenza virus type 4A fusion protein and gene coding for the same
09/10/1996US5554525 Chicken anemia virus vaccine and diagnostic
09/10/1996US5554524 More complex type retroviruses having mixed type LTR, and uses thereof
09/10/1996US5554515 Immunizing a non-human warm blooded animal with purifiedantigen; recovering an antibody producing cell; fusion of this cell to produce hybrid
09/10/1996US5554514 Production of recombinant human interferon beta2.sbsb.B
09/10/1996US5554513 Production of recombinant human interferon-beta2
09/10/1996US5554512 Isolated dna sequence encoding flt3 ligand polypeptide; expression vector comprising the sequence; host cell transformed or transfected with the vector; culture process for producing flt3-l polypeptide; nucleic acid sequences
09/10/1996US5554507 Bacillus subtilis siderophore genes
09/10/1996US5554506 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
09/10/1996US5554500 Cloned genes for human dopamine D2 receptors and cell lines expressing same
09/10/1996US5554499 Detection and isolation of ligands
09/10/1996US5554378 Pharmaceutical composition and its mucosal use
09/10/1996US5554371 Contains antigenic recombinant polypeptide with amino acid sequence corresponding to that of recombinant polypeptide produced by e. coli transformant atcc 68825; immunization process
09/10/1996CA2171242A1 Msrv-1 virus and pathogenic and/or infective msrv-2 related to rhumatoid arthritis
09/10/1996CA2131819E Control of male fertility using externally inducible promoter sequences
09/08/1996CA2171144A1 Human t-cell line infected with hiv-2 which secretes functionally intact hiv-2 gp160
09/06/1996WO1996027131A1 Anti dna antibody detection involving telomeric dna sequence recognition and binding
09/06/1996WO1996027130A1 Multiple drug resistance gene of aspergillus fumigatus
09/06/1996WO1996027128A2 Hiv determinants required for in vivo replication
09/06/1996WO1996027027A1 Improved method for purifying green fluorescent protein
09/06/1996WO1996027021A1 Interdependent adenoviral vectors and methods of using same
09/06/1996WO1996027020A1 Atherosclerosis gene therapy using monocyte line hdl production
09/06/1996WO1996027019A1 Transgenic animals as model of psoriasis
09/06/1996WO1996027018A1 A plasmid for expressing modified recombinant proteins in a bacterial system
09/06/1996WO1996027017A1 A method for expressing modified recombinant proteins in a bacterial system
09/06/1996WO1996027016A1 Methods and compositions for secretion of heterologous polypeptides
09/06/1996WO1996027015A2 A novel gene for a protein kinase associated with drug resistance
09/06/1996WO1996027013A1 Group o hiv-1, fragments of such viruses, and uses thereof
09/06/1996WO1996027012A1 Specific hiv-1 group o antigens
09/06/1996WO1996027011A1 A method for making heteromultimeric polypeptides
09/06/1996WO1996027009A1 Human amine transporter
09/06/1996WO1996027008A2 Agent for treating tumours and other hyperplasia
09/06/1996WO1996027007A1 A novel growth factor and a genetic sequence encoding same
09/06/1996WO1996027005A2 Recombinant dna molecules that code for polypeptides with antigenic properties of allergens clah8 and clah12
09/06/1996WO1996027003A1 A process for the preparation of factor ix from biological sources
09/06/1996WO1996026962A1 Mhc-antigen complexes for detecting and purifying antigen-specific t cells
09/06/1996WO1996026961A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use
09/06/1996WO1996026960A1 Fish basic fibroblast growth factor, dna and use of the same
09/06/1996WO1996026959A1 Human transcription factors and binding assays
09/06/1996WO1996026958A2 Eph RECEPTOR LIGAND ELF-2
09/06/1996WO1996026957A1 Glutamate transporters and genes coding for the same
09/06/1996WO1996026956A1 Protein phosphatase inhibitor
09/06/1996WO1996026954A1 FsF-1 AND THE EARLY DETECTION OF FIBROSIS
09/06/1996WO1996026953A1 FsF-1 AND THE EARLY DETECTION OF FIBROSIS
09/06/1996WO1996026952A1 Multiple drug resistance gene of aspergillus flavus
09/06/1996WO1996026744A1 Dna encoding natural killer lytic associated protein
09/06/1996WO1996026742A1 Gene transfer-mediated angiogenesis therapy
09/06/1996WO1996026740A1 Methods and compositions for production of customized vaccines for diseases associated with antigens of microorganisms
09/06/1996WO1996026737A1 Morphogen-induced dentine regeneration
09/06/1996WO1996026736A1 Vascular endothelial growth factor-b
09/06/1996WO1996026639A1 Cotton modification using ovary-tissue transcriptional factors
09/06/1996WO1996021728A3 Transgenic animals having a defective thyroid hormone receptor gene
09/06/1996WO1996021035A3 Retroviral delivery of full length factor VIII
09/06/1996WO1996021015A3 Combination gene delivery vehicles
09/06/1996WO1996021007A3 Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells
09/06/1996WO1996021000A3 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
09/06/1996WO1996020954A3 Functionally active domains of signal transducer and activators of transcription (STAT) proteins
09/06/1996WO1996020953A3 Synthetic multimeric peptide with delta hepatitis virus antigenic activity
09/06/1996WO1996020688A3 Triggered pore-forming agents
09/06/1996WO1996020277A3 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
09/06/1996WO1996020219A3 Murine monoclonal anti-idiotype antibody 3h1
09/06/1996WO1996018646A3 Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
09/06/1996WO1996017934A3 Cloning and recombinant production of crf receptor(s)
09/06/1996WO1996012804A3 Recombinant dna
09/06/1996CA2247207A1 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use
09/06/1996CA2214341A1 Morphogen-induced dentine regeneration
09/06/1996CA2213857A1 A method for expressing modified recombinant proteins in a bacterial system
09/06/1996CA2213734A1 A plasmid for expressing modified recombinant proteins in a bacterial system
09/06/1996CA2213669A1 Transgenic animals as model of psoriasis
1 ... 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 ... 2916